Microbial-derived Urolithin A Targets GLS1 to Inhibit Glutaminolysis and Attenuate Cirrhotic Portal Hypertension.
Li R, Liu Z, Huang W, Guo Y, Xie C, Wu H, Liu J, Hong X, Wang X, Huang J, Cai M, Guo Z, Liang L, Lin L, Zhu K.
Li R, et al.
Cell Mol Gastroenterol Hepatol. 2024;18(4):101379. doi: 10.1016/j.jcmgh.2024.101379. Epub 2024 Jul 20.
Cell Mol Gastroenterol Hepatol. 2024.
PMID: 39038605
Free PMC article.